Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Kensey Nash Corporation (NasdaqNM:KNSY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 31Price hit new 52-week high ($23.40)
Aug 16Conference call: Kensey Nash Earnings (Q4 2001)
Aug 15Earnings Announcement
Location
Marsh Creek Corporate Center
55 East Uwchlan Ave. Suite 204
Exton, PA 19341
Phone: (610) 524-0188
Fax: (610) 524-0265
Email: info@kenseynash.com
Employees (last reported count): 134
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 32%
·Over the last 6 months:
 · 5 insider sells; 134.0K shares
  (3.8% of insider shares)
·Institutional: 59% (87% of float)
(69 institutions)
·Net Inst. Buying: 413.0K shares (+6.25%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Kensey Nash Corporation designs, develops, manufactures and processes proprietary biomaterials products for the orthopedics, cardiology, drug/biologics delivery and wound care markets. The Company is also a leader in cardiovascular medical technology, specifically, arterial revascularization and puncture closure devices. The Company is in clinical trials with the Aegis Vortex System, a device designed to remove occlusive material from saphenous vein grafts implanted during coronary bypass surgeries. Additionally, the Company was the original designer, developer, and manufacturer of the Angio-Seal, a device designed to seal and close femoral artery punctures made during diagnostic and therapeutic cardiovascular catheterizations. In September 2000, the Company acquired THM Biomedical, Inc., a company focused on developing tissue engineering devices for the repair and replacement of musculoskeletal tissues.
More from Market Guide: Expanded Business Description

Financial Summary
Kensey Nash designs, develops, manufactures and markets, both individually and in conjunction with third parties, medical devices for use primarily in the cardiovascular and orthopedic markets. For the fiscal year ended 6/30/01, revenues rose 17% to $23.2 million. Net income fell 24% to $3.6 million. Revenues reflect growth in biomaterials sales and acquisitions. Net income was offset by a $7.6 million in-process research and development charge.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Joseph Kaufmann, 48
CEO, Pres, Sec.,
$209K
Wendy DiCicco, 61
CFO
99K
Douglas Evans, 36
COO, Assistant Sec.,
169K
John Nash, 65
VP of New Technologies
181K
Julie Broderick, 61
VP of Clinical and Regulatory Affairs
113K
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:KNSYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 17-Nov-2000
$8.875
Recent Price$22.87 
52-Week High
on 31-Aug-2001
$23.40 
Beta-0.01 
Daily Volume (3-month avg)106.4K
Daily Volume (10-day avg)209.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+77.6%
52-Week Change
relative to S&P500
+138.3%
Share-Related Items
Market Capitalization$239.2M
Shares Outstanding10.5M
Float7.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.96 
Earnings (ttm)$0.32 
Earnings (mrq)$0.61 
Sales (ttm)$2.19 
Cash (mrq)$2.50 
Valuation Ratios
Price/Book (mrq)4.61 
Price/Earnings (ttm)70.81 
Price/Sales (ttm)10.46 
Income Statements
Sales (ttm)$23.2M
EBITDA (ttm)-$2.13M
Income available to common (ttm)$3.62M
Profitability
Profit Margin (ttm)15.6%
Operating Margin (ttm)-9.2%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)6.73%
Return on Equity (ttm)7.38%
Financial Strength
Current Ratio (mrq)11.99 
Debt/Equity (mrq)0.04 
Total Cash (mrq)$27.0M
Short Interest
As of 8-Aug-2001
Shares Short508.0K
Percent of Float7.2%
Shares Short
(Prior Month)
459.0K
Short Ratio4.79 
Daily Volume106.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.